Andy LaFrence

Andy LaFrence is currently the Director at InSitu Biologics. Andy has also previously worked as the Chief Financial Officer and Chief Operating Officer at StemoniX, Inc. from August 2019 to March 2021. From February 2013 to May 2018, they were the Vice President of Finance and CFO at Surmodics. From June 2011 to May 2018, they were also a Board Director at Biothera Pharmaceuticals, Inc.

Andy LaFrence has a Bachelor of Science in Accounting from Illinois State University and is certified as a CPA.